Brafk601e mutation in a patient with a follicular thyroid carcinoma

Thyroid

Volumn 21, Issue 12, 2011, Pages 1393-1396

  Pennelli, Gianmaria ^a   Vianello, Federica ^b   Barollo, Susi ^b   Pezzani, Raffaele ^a   Boschin, Isabella Merante ^a   Pelizzo, Maria Rosa ^a   Mantero, Franco ^a   Rugge, Massimo ^a   Mian, Caterina ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; LIOTHYRONINE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE GAMMA; PROTEIN KINASE B; PROTEIN P70; THYROGLOBULIN; THYROTROPIN; THYROXINE; BRAF PROTEIN, HUMAN; GALECTIN 3; MAPK1 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PIK3CA PROTEIN, HUMAN; TUMOR MARKER;

AGED; ARTICLE; ASPIRATION BIOPSY; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CASE REPORT; CELL POPULATION; CYTOLOGY; ENZYME ACTIVATION; EXON; GENE MUTATION; GOITER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LIOTHYRONINE BLOOD LEVEL; LYMPH NODE DISSECTION; MALE; ONCOGENE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SINGLE BLIND PROCEDURE; THYROGLOBULIN BLOOD LEVEL; THYROID FOLLICULAR CARCINOMA; THYROID FUNCTION TEST; THYROID NODULE; THYROID WEIGHT; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TUMOR DIFFERENTIATION; TUMOR VOLUME; DISSECTION; ENZYMOLOGY; GENETICS; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MUTATION; NEEDLE BIOPSY; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHOSPHORYLATION; THYROID TUMOR; WESTERN BLOTTING;

AGED; BIOPSY, FINE-NEEDLE; BLOTTING, WESTERN; DISSECTION; DNA MUTATIONAL ANALYSIS; GALECTIN 3; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUTATION; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS C-AKT; THYROID NEOPLASMS; THYROIDECTOMY; TUMOR MARKERS, BIOLOGICAL;

EID: 82955165727     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2011.0120     Document Type: Article

References (19)

1. DeLellis RA, Lloyd R, Heitz P, Eng C 2004 World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs. IARC Press, Lyon.
2. Bahar G, Braslavsky D, Shpitzer T, Feinmesser R, Avidan S, Popovtzer A, Karl S 2003 The cytological and clinical value of the thyroid ''follicular lesion.'' Am J Otolaringol 24: 217-220. (Pubitemid 36944460)
3. Nikiforov YE, Steward DL, Robinson-Smith TM, Haugen BR, Klopper JP, Zhu Z, Fagin JA, Falciglia M, Weber K, Nikiforova MN 2009 Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab 94:2092-2098.
4. Gilfillan CP 2010 Review of the genetics of thyroid tumours: diagnostic and prognostic implications. ANZ J Surg 80: 33-40.
5. Castro P, Rebocho AP, Soares RJ, Magalhães J, Roque L, Trovisco V, Vieira de Castro I, Cardoso-de-Oliveira M, Fonseca E, Soares P, Sobrinho-Simões M 2006 PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma. J Clin Endocrinol Metab 91:213-220. (Pubitemid 43069140)
6. Perros P 2007 Guidelines for the Management of Thyroid Cancer, 2nd edition. Report of the Thyroid Cancer Guidelines Update Group. British Thyroid Association. Royal College of Physicians, London.
7. Pennelli G, Mian C, Pelizzo MR, Naccamulli D, Piotto A, Girelli ME, Mescoli C, Rugge M 2009 Galectin-3 cytotest in thyroid follicular neoplasia: a prospective, monoinstitutional study. Acta Cytol 53:533-539.
8. Xu X, Quiros RM, Gattuso P, Ain KB, Prinz RA 2003 High prevalence of BRAF gene mutation in papillary thyroid arcinomas and thyroid tumor cell lines. Cancer Res 63: 4561-4567. (Pubitemid 36951030)
9. Sadow PM, Heinrich MC, Corless CL, Fletcher JA, Nosé V 2010 Absence of BRAF, NRAS, KRAS, HRAS mutations, and RET/PTC gene rearrangements distinguishes dominant nodules in Hashimoto thyroiditis from papillary thyroid carcinomas. Endocr Pathol 21:73-79.
10. Sobin LH, Gospodarowicz MK, Wittekind CH (eds) 2009 International Union Against Cancer (UICC) TNM Classification of Malignant Tumours, 7th ed. Oxford: Wiley-Blackwell, pp 58-62.
11. Nikiforova MN, Lynch RA, Biddinger PW, Alexander EK, Dorn GW 2nd, Tallini G, Kroll TG, Nikiforov YE 2003 RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab 88: 2318-2326. (Pubitemid 36549913)
12. Hou P, Liu D, Shan Y, Hu S, Studeman K, Condouris S, Wang Y, Trink A, El-Naggar AK, Tallini G, Vasko V, Xing M 2007 Genetic alterations and their relationship in the phosphatidylinositol 3-kinase/Akt pathway in thyroid cancer. Clin Cancer Res 13:1161-1170. (Pubitemid 46424056)
13. Nikiforova MN, Kimura ET, Gandhi M, Biddinger PW, Knauf JA, Basolo F, Zhu Z,Giannini R, Salvatore G, Fusco A, Santoro M, Fagin JA, Nikiforov YE 2003 BRAF mutation in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab 88:5399-5404. (Pubitemid 37452745)
14. Trovisco V, Soares P, Preto A, de Castro IV, Lima J, Castro P, Máximo V, Botelho T, Moreira S, Meireles AM, Magalhães J, Abrosimov A, Cameselle-Teijeiro J, Sobrinho-Simões M 2005 Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness. Virchows Arch 446:589-595. (Pubitemid 40922263)
15. Kebebew E, Weng J, Bauer J, Ranvier G, Clark OH, Duh QY, Shibru D, Bastian B, Griffin A 2007 The prevalence and prognostic value of BRAF mutation in thyroid cancer. Ann Surg 246:466-470. (Pubitemid 47312140)
16. Xing M 2010 Genetic alterations in the phosphatidylinositol-3 kinase/Akt pathway in thyroid cancer. Thyroid 20: 697-706.
17. Hou P, Liu D, Shan Y, Hu S, Studeman K, Condouris S, Wang Y, Trink A, El-Naggar AK, Tallini G, Vasko V, Xing M 2007 Genetic alterations and their relationship in the phosphatidylinositol 3-kinase/Akt pathway in thyroid cancer. Clin Cancer Res 13:1161-1170. (Pubitemid 46424056)
18. Dufner A, Thomas G 1999 Ribosomal S6 kinase signaling and the control of translation. Exp Cell Res 253:100-109.
19. Pelizzo MR, Merante Boschin I, Barollo S, Pennelli G, Toniato A, Zambonin L, Vianello F, Piotto, Casal Ide E, Pagetta C, Sorgato N, Torresan F, Girelli ME, Nacamulli D, Mantero F, Mian C 2011 The BRAF analysis by FNAB of thyroid nodules improves preoperative identification of papillary thyroid carcinoma and represents a prognostic factor. A monoinstitutional experience. Clin Chem Lab Med 49:325-329.